Sign in

CIK 0001253689

  • Non-accelerated filer
  • Smaller reporting company

CRESCENT BIOPHARMA, INC.

Sign in to watch
Ticker
CBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Cayman Islands
Entity type
Operating
Phone
+1 617-430-5595
Business address
300 FIFTH AVENUE, WALTHAM, MA, 02451
Former names
GLYCOMIMETICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$285,501
in 7 filings, $286K under 10b5-1 plans

Net −$285,501. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-05-01 Koenig Scott Director Grant or award · Stock Option (right to buy) +40,000 40,000
2023-06-01 Koenig Scott Director Exercise or conversion +21,000 $0.60 $13K 36,750
2023-06-01 Koenig Scott Director Exercise or conversion · Stock option (right to buy) −21,000 0
2023-05-19 Koenig Scott Director Grant or award · Stock Option (right to buy) +35,000 35,000
2023-01-27 Koenig Scott Director Exercise or conversion +10,500 $2.55 $27K 15,750
2023-01-27 Koenig Scott Director Exercise or conversion · Stock Option (right to buy) −10,500 0
2022-05-18 Koenig Scott Director Grant or award · Stock Option (right to buy) +21,000 21,000
2021-05-18 Koenig Scott Director Grant or award +5,250 5,250
2021-05-18 Koenig Scott Director Grant or award · Stock Option (right to buy) +10,500 10,500
2020-05-22 Koenig Scott Director Grant or award · Stock Option (right to buy) +21,000 21,000
2019-05-17 Koenig Scott Director Grant or award · Stock Option (right to buy) +21,000 21,000
2018-05-18 Koenig Scott Director Grant or award · Stock Option (right to buy) +11,000 11,000
2017-05-25 Koenig Scott Director Grant or award · Stock Option (right to buy) +11,000 11,000
2017-03-09 Koenig Scott Director Grant or award · Stock Option (right to buy) +22,000 22,000

Page 1 of 1 · 14 trades